We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Colorectal Cancer Blood Test Driven by Immuno-transcriptomics
Industry Insight

By studying gene expression modifications induced by the immune response, Novigenix has developed a blood test for colorectal cancer. This Q&A with Jan Groen, CEO, provides insights on the test, and on the field of study that could revolutionize cancer diagnosis.

Read More

DNA Methylation Analysis for Early Detection of Various Cancers
Industry Insight

We recently spoke to Richard Brand, CFO and Dhruvajyoti Roy, Director of Technology from the Laboratory for Advanced Medicine (LAM) to learn more about how LAM is developing methylation-based tests for the early detection and intervention of cancer.

Read More

Why Should Antibodies Be Manufactured Recombinantly?
Industry Insight

Given that bad antibodies are likely to blame for a significant proportion of the reproducibility crisis in science, any efforts to reduce batch-to-batch variability are more than welcome. One company with a plan to help in this area is “Absolute Antibody”, who believe that recombinant antibodies are the way forward. To learn more about making antibodies with recombinant technology, we spoke to Ian Wilkinson, PhD, Chief Scientific Officer.

Read More

A Microfluidic Approach to Gene Delivery in GMCT
Industry Insight

The development of GMCTs has been halted by issues surrounding the most critical step in their creation, the introduction of new genetic material. Recently, Indee Labs announced the publication of a study illustrating the efficacy of it's GMCT development and manufacturing technology. We spoke with Indee Labs' CEO Ryan Pawell to learn more about the technology and its applications.

Read More

Single-cell DNA Analysis: Driving Dynamic Changes in the Treatment of Cancer
Industry Insight

We recently spoke to Charlie Silver, CEO and Co-Founder of Mission Bio, to learn more about how they are helping researchers profile mutational heterogeneity at the single-cell level.

Read More

Talking Genes, Exercise and Nutrition With DNAFit
Industry Insight

DNAfit is a personalized health and wellness company that offers an array of nutritional profiling services based on genetic science and technology. We spoke with Avi Lasarow, CEO and founder of DNAFit, to learn more about why it is important to look at our genetics in relation to diet and exercise choices, and what research currently exists in the field.

Read More

Hitting the Target With NGS Advances
Industry Insight

This year’s Advances in Genome Biology and Technology meeting showcased some of the most exciting developments in genomic technology. We caught up with Twist Bioscience CEO Emily Leproust to discuss the importance of target enrichment in next generation sequencing and the advancements in the field that caught her eye at AGBT.

Read More

Releasing the Handbrake on Exosome Applications
Industry Insight

Despite the great excitement about exosomes and their huge diagnostic and therapeutic potential, the technology needed to advance this work is lacking. We spoke to Jim West, CEO of Clara Biotech, who tells us how his team is working to fill that gap.

Read More

Proteogenomics, Precision Medicine and Oncology
Industry Insight

Major advances have occurred in the fields of proteomics and genomics over recent years. Now, scientists are utilizing the technologies from each approach collectively in a novel research area named proteogenomics. We spoke with Alexzander Asea, Professor and Director at Precision Therapeutics Proteogenomics Diagnostics Center, University of Toledo, to learn more about the applications of proteogenomics in precision medicine.

Read More

Keeping Cell and Gene Therapies Alive in Transit
Industry Insight

Cryoport is the single largest cryogenic delivery system for immunotherapy drugs, and the sole cryogenics logistics provider for the first two commercialized cell therapies. To learn more about the company providing the logistics backbone of clinical trials for regenerative medicine, we caught up with Mark Sawicki, chief commercial officer.

Read More

 
Advertisement